Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Net Cash Flow: 2013-2024

Historic Net Cash Flow for vTv Therapeutics (VTVT) over the last 12 years, with Dec 2024 value amounting to $27.3 million.

  • vTv Therapeutics' Net Cash Flow rose 1935.20% to $72.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.9 million, marking a year-over-year increase of 70.80%. This contributed to the annual value of $27.3 million for FY2024, which is 1118.66% up from last year.
  • Per vTv Therapeutics' latest filing, its Net Cash Flow stood at $27.3 million for FY2024, which was up 1,118.66% from -$2.7 million recorded in FY2023.
  • In the past 5 years, vTv Therapeutics' Net Cash Flow registered a high of $27.3 million during FY2024, and its lowest value of -$2.7 million during FY2023.
  • Its 3-year average for Net Cash Flow is $7.8 million, with a median of -$1.3 million in 2022.
  • Per our database at Business Quant, vTv Therapeutics' Net Cash Flow spiked by 1,463.83% in 2020 and then plummeted by 116.81% in 2022.
  • Over the past 5 years, vTv Therapeutics' Net Cash Flow (Yearly) stood at $1.5 million in 2020, then spiked by 421.63% to $7.7 million in 2021, then plummeted by 116.81% to -$1.3 million in 2022, then slumped by 107.91% to -$2.7 million in 2023, then surged by 1,118.66% to $27.3 million in 2024.